期刊
ACS CHEMICAL NEUROSCIENCE
卷 9, 期 4, 页码 817-823出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.7b00439
关键词
Synergistic inhibitory effect; cytotoxicity; amyloid beta (A beta) peptide; graphene quantum dots (GQDs); tramiprosate
资金
- National Natural Science Foundation of China (NSFC) [21475009, 21475008]
- Beijing Municipal Science & Technology Commission [Z161100000116037]
Inhibiting the amyloid aggregation is considered to be an effective strategy to explore possible treatment of amyloid-related diseases including Alzheimer's disease, Parkinson's disease, and type II diabetes. Herein, a new high-efficiency and low-cytotoxicity A beta aggregation inhibitors, GQD-T, was designed through the combination of two A beta aggregation inhibitors, graphene quantum dots (GQDs) and tramiprosate. GQD-T showed the capability of efficiently inhibiting the aggregation of A beta peptides and rescuing A beta-induced cytotoxicity due to the synergistic effect of the GQDs and tramiprosate. In addition, the GQD-T has the characteristics of low toxicity and great biocompatibility. It is believed that GQD-T may be a potential candidate for an Alzheimer's drug and this work provides a new strategy for exploring A beta peptide aggregation inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据